87 FR 44 pg. 12710 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—CE22-003, Rigorously Evaluating Programs and Policies To Prevent Child Sexual Abuse (CSA); Amended Notice of Meeting
Type: NOTICEVolume: 87Number: 44Page: 12710
Page: 12710FR document: [FR Doc. 2022-04681 Filed 3-4-22; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-CE22-003, Rigorously Evaluating Programs and Policies To Prevent Child Sexual Abuse (CSA); Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)- CE22-003, Rigorously Evaluating Programs and Policies to Prevent Child Sexual Abuse (CSA), April 19-20, 2022, 8:30 a.m., EDT-5:30 p.m., EDT, Web Conference, in the original FRN. The meeting was published in the Federal Register on January 14, 2022, Volume 87, Number 10, page 2439.
The meeting is being amended to change the meeting date and should read as follows:
CE22-003, Rigorously Evaluating Programs and Policies to Prevent Child Sexual Abuse (CSA): April 19, 2022.
The meeting is closed to the public.
FOR FURTHER INFORMATION CONTACT:
Aisha L. Wilkes, M.P.H., Scientific Review Officer, National Center for Injury Prevention and Control, CDC, 4770 Buford Highway NE, Mailstop S106-9, Atlanta, Georgia 30341, Telephone (404) 639-6473, AWilkes@cdc.gov.
The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-04681 Filed 3-4-22; 8:45 am]
BILLING CODE 4163-18-P